Sunday 18 October 2026
Export IVF’s income statement to Excel — free account
INVO Fertility, Inc
IVF Healthcare Medical Devices
INVO Fertility, Inc’s revenue for fiscal 2025 (year ended December 2025) was $6.8 million, up 4.74% from fiscal 2024. In the quarter to June 2026, revenue grew 16.7%, EPS grew 100.1%, free cash flow grew 35.1% and total debt fell 50.7%, each against the same quarter a year earlier. Revenue growth for three consecutive years.
0.56
0.03
−5.08%
Follow IVF
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Piotroski F-Score |
4 | 4 | 5 | 2 | 5 | 6 | 7 | 4 | 4 | 4 |
P/S ratio |
0.06 | 0.54 | 0.61 | 6.15 | 9.22 | 16.71 | 26.92 | 115,368,949.17 | 69,243,011.43 | 883,505,236.93 |
Altman Z-Score |
(7.60) | (2.75) | (5.79) | (28.27) | 1.42 | (2.79) | (16.71) | 9,771,514.27 | 2,302,209.30 | 5,492,046.57 |
Altman Z″-Score (non-manufacturers) |
(19.01) | (7.70) | (14.98) | (68.02) | (9.86) | (6.88) | (50.60) | (138.07) | (365.79) | (358.54) |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 30.52 | 0.00 | 0.00 | 0.00 |
Beneish M-Score |
(1.33) | (2.46) | (1.59) | — | 4.79 | (1.80) | (8.55) | (16.27) | (3.39) | (30.06) |
P/Operating CF |
17.50 | (5.67) | (2.58) | (5.04) | (25.39) | (9.52) | (51.68) | (199,116,171.69) | (1,001,715,565.31) | (455,655,492.75) |
P/B ratio |
0.09 | 0.00 | 0.00 | 0.00 | 5.25 | 3.02 | 0.00 | 0.00 | 0.00 | 0.00 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 5.34 | 3.07 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
(0.11) | 1.41 | 1.64 | 9.28 | 8.37 | 7.55 | 26.34 | 115,368,949.44 | 69,243,011.84 | 883,505,236.72 |
EV/EBITDA |
0.14 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
0.11 | (3.09) | (1.04) | (1.16) | (5.77) | (1.64) | 28.45 | (87,330,584.54) | (107,741,057.03) | (138,567,662.94) |
EV/FCF |
0.11 | (2.98) | (0.95) | (1.15) | (5.34) | (1.61) | 29.86 | (87,330,584.54) | (107,741,057.03) | (138,567,662.94) |
Quick Ratio |
0.22 | 0.04 | 0.05 | 0.05 | 4.58 | 4.42 | 0.83 | 0.13 | 0.02 | 0.03 |
Current Ratio |
0.27 | 0.07 | 0.16 | 0.19 | 5.03 | 4.61 | 1.03 | 0.21 | 0.05 | 0.05 |
Net Debt/EBITDA |
0.25 | (0.10) | (0.17) | (0.15) | 0.98 | 3.18 | 0.61 | 0.02 | (0.50) | 0.01 |
Debt/Assets |
3.68% | 2.45% | 6.78% | 45.02% | 18.17% | 5.43% | 20.94% | 20.20% | 128.60% | 49.51% |
Debt/Equity |
0.10 | 0.09 | 1.40 | (1.71) | 0.26 | 0.10 | (0.10) | (0.06) | (0.07) | (0.03) |
Asset Turnover |
0.21 | 0.20 | 0.27 | 0.12 | 0.39 | 0.16 | 1.15 | 0.95 | 1.02 | 0.12 |
Operating CF/Net income |
0.28 | 0.31 | 0.59 | 0.61 | 0.91 | 0.57 | (0.63) | 0.21 | 0.26 | 0.15 |
Capex/Depreciation |
(0.02) | (0.07) | (0.48) | (0.10) | (0.34) | (0.04) | (0.32) | (0.05) | 0.00 | (8.26) |
Interest Coverage |
(5.56) | (6.40) | (7.31) | (178.90) | (4.12) | (1.94) | (4.60) | (5.96) | (30.64) | (152.93) |
| 387.43% | 83.06% | 264.08% | (343.99%) | (101.96%) | (822.60%) | 67.34% | 79.73% | 14.61% | 50.73% | |
| (75.81%) | (29.45%) | (72.33%) | (153.67%) | (62.16%) | (131.01%) | (168.49%) | (589.46%) | (254.14%) | (490.60%) | |
ROIC |
(76.78%) | (31.64%) | (220.95%) | (1,102.70%) | (92.43%) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
349.81% | 58.90% | 135.80% | 477.70% | (119.82%) | (99.53%) | (1,600.81%) | 112.43% | 14.40% | 47.15% |
Average Days of Receivables |
11.59 | 6.32 | 16.99 | 34.23 | 4.43 | 7.64 | 1.87 | 166.77 | 112.18 | 20.08 |
Research and Development Expense of Revenue |
0.00% | 0.08% | 5.49% | 66.16% | 5.20% | 38.41% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
112.42% | 123.48% | 247.85% | 1,213.40% | 216.71% | 584.70% | 211.36% | 614.50% | 308.61% | 4,216.50% |
Intangible Assets out of Total Assets |
0.36 | 0.20 | 0.54 | 0.00 | 0.01 | 0.01 | 0.03 | 0.02 | 0.06 | 0.07 |
Share Based Compensation of Revenue |
18.86% | 19.09% | 11.40% | 73.95% | 27.99% | 59.38% | 4.31% | 423.28% | 76.25% | 2,482.51% |
Graham Net Nets |
(23.20) | (9.21) | (8.87) | (0.80) | 0.08 | 0.31 | (0.10) | 0.00 | 0.00 | 0.00 |
Graham Number |
1,220.36 | 21,583.50 | 30,214.18 | 37,763.13 | 0.00 | 0.00 | 48,563.72 | 0.09 | 0.06 | 0.11 |
Earnings Yield |
42,636.66% | (299.32%) | (430.99%) | (205.11%) | (18.83%) | (50.71%) | (2.83%) | 0.00% | 0.00% | 0.00% |
Free Cash Flow Yield |
(1,600.54%) | (88.15%) | (282.20%) | (130.82%) | (16.98%) | (28.06%) | 3.28% | 0.00% | 0.00% | 0.00% |
Revenue per Share |
58.47 | 2,177.33 | 3,020.60 | 2,055.50 | 10,400.25 | 5,186.50 | 7,401.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(59.95) | (991.47) | (4,755.10) | (16,508.25) | (15,074.75) | (23,875.50) | 6,852.50 | 0.00 | 0.00 | 0.00 |
Capex per Share |
(0.37) | (36.03) | (444.70) | (31.75) | (1,136.50) | (445.00) | (573.50) | 0.00 | 0.00 | 0.00 |
Free Cash Flow per Share |
(60.32) | (1,027.50) | (5,199.80) | (16,540.00) | (16,211.25) | (24,320.50) | 6,279.00 | 0.00 | 0.00 | 0.00 |
Cash per Share |
17.76 | 206.50 | 232.40 | 225.25 | 14,212.25 | 50,489.00 | 6,193.00 | 0.00 | 0.00 | 0.00 |
Shareholders Equity per Share |
61.75 | 4,194.80 | 892.60 | (2,444.00) | 18,276.75 | 28,715.50 | (18,568.00) | (0.02) | (0.04) | (0.03) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
61.75 | 4,194.80 | 892.60 | (2,444.00) | 18,276.75 | 28,715.50 | (18,568.00) | (0.02) | (0.04) | (0.03) |
Free Cash Flow |
(7.06) | (3.08) | (5.20) | (6.62) | (6.48) | (4.86) | 1.26 | (0.67) | (0.18) | (0.34) |
Working Capital |
(7.57) | (16.61) | (6.74) | (2.72) | 5.05 | 8.25 | 0.04 | (2.77) | (4.89) | (4.52) |
Capital Expenditures |
(0.04) | (0.11) | (0.44) | (0.01) | (0.45) | (0.09) | (0.11) | (0.02) | — | (0.02) |
Net Current Asset Value |
(10.23) | (32.24) | (16.35) | (4.07) | 3.15 | 5.34 | (3.97) | (2.77) | (5.02) | (4.65) |
EV/EBIT |
0.10 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.01 | 0.02 | 0.15 | 0.02 | 0.11 | 0.09 | 0.08 | 0.04 | 0.00 | 0.31 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
4.82 | 3.30 | 1.11 | 0.30 | 2.70 | 19.13 | 3.90 | 10.79 | 0.18 | 0.12 |
Cash ROIC |
(70.25%) | (21.51%) | (218.57%) | (845.50%) | (43.53%) | (29.59%) | (59.83%) | 28.55% | 3.92% | 7.85% |
Accounts Receivable Turnover |
41.41 | 51.49 | 27.75 | 12.89 | 115.24 | 70.81 | 12.68 | 3.16 | 6.30 | 24.83 |
Accounts Payable Turnover |
1.68 | 1.34 | 1.05 | 0.95 | 0.38 | 0.25 | 0.28 | 0.12 | 0.05 | 0.02 |
Inventory Turnover |
19.38 | 15.11 | 7.33 | 3.09 | 0.52 | 0.48 | 1.85 | 1.77 | 0.72 | 0.20 |
Average Days of Payables |
172.15 | 310.71 | 439.72 | 578.73 | 1,115.38 | 1,351.90 | 1,014.19 | 2,308.71 | 6,743.38 | 23,565.46 |
Days of Inventory on Hand |
19.07 | 21.93 | 49.91 | 113.09 | 723.96 | 1,090.89 | 276.82 | 175.64 | 413.43 | 2,059.47 |
Average Receivables |
0.17 | 0.13 | 0.11 | 0.06 | 0.04 | 0.01 | 0.12 | 0.16 | 0.04 | 0.00 |
Average Payables |
2.57 | 2.72 | 1.84 | 0.90 | 0.39 | 0.35 | 0.47 | 0.77 | 0.97 | 1.00 |
Average Inventory |
0.22 | 0.24 | 0.26 | 0.28 | 0.28 | 0.18 | 0.07 | 0.05 | 0.07 | 0.08 |
Average Assets |
33.15 | 32.29 | 11.11 | 7.09 | 10.71 | 6.37 | 1.29 | 0.52 | 0.28 | 0.43 |
Average Common Equity |
(6.49) | (11.45) | (3.04) | 3.17 | 6.53 | 1.01 | (3.22) | (3.86) | (4.80) | (4.19) |
Columns are period end dates